161 related articles for article (PubMed ID: 38716401)
21. Cost evaluation of continuation of therapy with dalbavancin compared to standard-of-care antibiotics alone in hospitalized persons who inject drugs with severe gram-positive infections.
Donnelly D; Pillinger KE; Debnath A; DePasquale W; Munsiff S; Louie T; Jones CMC; Shulder S
Am J Health Syst Pharm; 2024 May; 81(Supplement_2):S40-S48. PubMed ID: 38465838
[TBL] [Abstract][Full Text] [Related]
22. Incidence and Predictors of Gram-Negative Bacilli in Hospitalized People Who Inject Drugs with Injection Drug Use-Attributable Infections.
Kelly MC; Yeager SD; Shorman MA; Wright LR; Veve MP
Antimicrob Agents Chemother; 2021 Nov; 65(12):e0092521. PubMed ID: 34543093
[TBL] [Abstract][Full Text] [Related]
23. Dalbavancin in clinical practice: a particular place for the elderly?
Wackenheim C; Le Maréchal M; Pluchart H; Gavazzi G; Blanc M; Caspar Y; Pavese P;
Eur J Clin Microbiol Infect Dis; 2022 Jun; 41(6):977-979. PubMed ID: 35471751
[TBL] [Abstract][Full Text] [Related]
24. The hidden cost of dalbavancin: OPAT RN time required in coordination for persons who use drugs.
Douglass AH; Mayer H; Young K; Sikka MK; Strnad L; Makadia J; Sukerman E; Lewis JS; Streifel AC
Ther Adv Infect Dis; 2023; 10():20499361231189405. PubMed ID: 37581105
[TBL] [Abstract][Full Text] [Related]
25. Clinical Characteristics and Factors Associated With Mortality in First-Episode Infective Endocarditis Among Persons Who Inject Drugs.
Rodger L; Glockler-Lauf SD; Shojaei E; Sherazi A; Hallam B; Koivu S; Gupta K; Hosseini-Moghaddam SM; Silverman M
JAMA Netw Open; 2018 Nov; 1(7):e185220. PubMed ID: 30646383
[TBL] [Abstract][Full Text] [Related]
26. Dalbavancin for the treatment of acute bacterial skin and skin structure infections.
Ramdeen S; Boucher HW
Expert Opin Pharmacother; 2015; 16(13):2073-81. PubMed ID: 26239321
[TBL] [Abstract][Full Text] [Related]
27. Low mortality but increasing incidence of Staphylococcus aureus endocarditis in people who inject drugs: Experience from a Swedish referral hospital.
Asgeirsson H; Thalme A; Weiland O
Medicine (Baltimore); 2016 Dec; 95(49):e5617. PubMed ID: 27930590
[TBL] [Abstract][Full Text] [Related]
28. Evaluating the Use of Dalbavancin for Off-Label Indications.
Taylor K; Williamson J; Luther V; Stone T; Johnson J; Gruss Z; Russ-Friedman C; Ohl C; Beardsley J
Infect Dis Rep; 2022 Apr; 14(2):266-272. PubMed ID: 35447884
[TBL] [Abstract][Full Text] [Related]
29. Dalbavancin for treating prosthetic joint infections caused by Gram-positive bacteria: A proposal for a low dose strategy. A retrospective cohort study.
Buzón Martín L; Mora Fernández M; Perales Ruiz JM; Ortega Lafont M; Álvarez Paredes L; Morán Rodríguez MA; Fernández Regueras M; Machín Morón MA; Mejías Lobón G
Rev Esp Quimioter; 2019 Dec; 32(6):532-538. PubMed ID: 31642637
[TBL] [Abstract][Full Text] [Related]
30. Clinical failure of dalbavancin for MRSA bacteremia in patient with severe obesity and history of IVDU.
Ritchie H; Aggarwal A; Schimmel J; Lorenzo MP
J Infect Chemother; 2022 Mar; 28(3):465-468. PubMed ID: 35016828
[TBL] [Abstract][Full Text] [Related]
31. Outcomes in Patients with Staphylococcus aureus Bacteremia Treated with Dalbavancin in Clinical Trials.
Gonzalez PL; Rappo U; Akinapelli K; McGregor JS; Puttagunta S; Dunne MW
Infect Dis Ther; 2022 Feb; 11(1):423-434. PubMed ID: 34905144
[TBL] [Abstract][Full Text] [Related]
32. Community-Acquired Staphylococcus aureus Bacteremia Among People Who Inject Drugs: A National Cohort Study in England, 2017-2020.
McGuire E; Collin SM; Brown CS; Saito M
Clin Infect Dis; 2024 Jun; 78(6):1443-1450. PubMed ID: 38315893
[TBL] [Abstract][Full Text] [Related]
33. Real-World Data Regarding Dalbavancin Use before and during the COVID-19 Pandemic-A Single-Center Retrospective Study.
Ioannou P; Wolff N; Mathioudaki A; Spanias C; Spernovasilis N; Kofteridis DP
Antibiotics (Basel); 2023 Jul; 12(7):. PubMed ID: 37508301
[TBL] [Abstract][Full Text] [Related]
34. Successful use of dalbavancin in the treatment of gram positive blood stream infections: a case series.
Evins C; Lancaster H; Schnee AE
Ann Clin Microbiol Antimicrob; 2022 Apr; 21(1):16. PubMed ID: 35473711
[TBL] [Abstract][Full Text] [Related]
35. Successful treatment of methicillin-sensitive Staphylococcus aureus tricuspid-valve endocarditis with dalbavancin as an outpatient in a person who injects drugs: A case report.
Hakim A; Braun H; Thornton D; Strymish J
Int J Infect Dis; 2020 Feb; 91():202-205. PubMed ID: 31841726
[TBL] [Abstract][Full Text] [Related]
36. Dalbavancin in the treatment of different gram-positive infections: a real-life experience.
Bouza E; Valerio M; Soriano A; Morata L; Carus EG; Rodríguez-González C; Hidalgo-Tenorio MC; Plata A; Muñoz P; Vena A;
Int J Antimicrob Agents; 2018 Apr; 51(4):571-577. PubMed ID: 29180276
[TBL] [Abstract][Full Text] [Related]
37. Real world utilization of Dalbavancin at a rural community emergency department.
Dolan A; Kuge E; Bremmer E; Dietrich T; Santarelli A; Ashurst J
Am J Emerg Med; 2022 Apr; 54():253-256. PubMed ID: 35190304
[TBL] [Abstract][Full Text] [Related]
38. Real-life experience with IV dalbavancin in Canada; results from the CLEAR (Canadian LEadership on Antimicrobial Real-life usage) registry.
Zhanel G; Silverman M; Malhotra J; Baxter M; Rahimi R; Irfan N; Girouard G; Dhami R; Kucey M; Stankus V; Schmidt K; Poulin S; Connors W; Tascini C; Walkty A; Karlowsky J
J Glob Antimicrob Resist; 2024 Jun; ():. PubMed ID: 38908823
[TBL] [Abstract][Full Text] [Related]
39. 'Care and Prevent': rationale for investigating skin and soft tissue infections and AA amyloidosis among people who inject drugs in London.
Harris M; Brathwaite R; McGowan CR; Ciccarone D; Gilchrist G; McCusker M; O'Brien K; Dunn J; Scott J; Hope V
Harm Reduct J; 2018 May; 15(1):23. PubMed ID: 29739408
[TBL] [Abstract][Full Text] [Related]
40. A Multicentre, Prospective, and Retrospective Registry to Characterize the Use, Effectiveness, and Safety of Dalbavancin in German Clinical Practice.
Hanses F; Dolff S; Trauth J; Seimetz M; Hagel S
Antibiotics (Basel); 2022 Apr; 11(5):. PubMed ID: 35625206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
